What Visionary Holdings does

Visionary Holdings Inc. (NASDAQ: GV) is a Toronto-headquartered holding company that has completed a strategic pivot from education technology—its original business at the May 2022 NASDAQ IPO—into regenerative medicine, anti-aging medical aesthetics, and biotechnology. Founded in 2013 (originally as 123 Natural Food Ontario Ltd.) and rebranded in 2021, the company divested its non-core education subsidiary in February 2026 and now concentrates on medical-grade stem cell anti-aging products, the RAMU anti-aging line, the Premier Regenerative Complex-President Super Injection injectable, and the V-Series anti-aging portfolio, supported by proprietary technologies including a Nano-Delivery Smart Transdermal System, an AI-Based Aging Assessment Model, Telomerase Homeostasis Technology, NK Cell Revitalization programs, and a global license for stem cell diabetes treatment held through the Visionary Yike Stemcell Technologies joint venture (85% GV / 15% Jiangsu Yike).

The company serves high-net-worth individuals and premium consumers seeking cellular rejuvenation, full-genome sequencing, and personalized longevity management, alongside a secondary use case in diabetes patients via stem cell therapy. Revenue is generated through a hybrid model combining direct-to-consumer premium services, B2B exclusive distribution agreements (Huajin China for $12M, Chushanji Digital Technology across ~10,000 stores in 105 Chinese districts), global technology licensing, and milestone-based investment partnerships (the $20M Qingdao Xihai Rongke anti-aging project). Pricing is quote-based and not publicly disclosed, with large anchor distribution agreements and recurring VIP health services forming the primary revenue mechanics.

Visionary Holdings operates through a network of wholly-owned regional subsidiaries and joint ventures spanning Canada (Toronto headquarters and planned Toronto Anti-Aging High-End Medical Aesthetics Center), Hong Kong (Asia-Pacific commercial platform GV Hong Kong), and mainland China (regional entities in Hangzhou, Nanjing, Qingdao, Wuxi, and Wuhu covering the Shandong Peninsula, Yangtze River Delta biomedical corridor, and Anhui healthcare market), with complementary subsidiaries in new energy vehicles (PEGASUS), green energy/HVAC (SBS/Smarco), and Traditional Chinese Medicine (51% Sikang Guangzhou). The company claims over 150 self-developed patents and reports 100+ staff (100% bachelor's degree or above), with total assets of approximately USD 68.8 million as of fiscal 2025.

Name

Visionary Holdings

Legal name

Visionary Holdings Inc.

Website

https://www.visionary.holdings

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

Visionary Holdings Inc. is a Toronto-based NASDAQ-listed holding company (GV) that has pivoted from education technology to regenerative medicine and anti-aging medical aesthetics, operating through Chinese regional subsidiaries and distribution partnerships to serve high-net-worth individuals and premium consumers across North America and Asia.

Ownership category

akta.pro rank

Product category

Regenerative Medicine and Anti-Aging Medical Aesthetics

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Stem Cell–Based Regenerative Therapies (HLAAAGAA)

akta.pro secondary industries

Anti-Aging & Firming Treatments (HSALADAC), Healthy Aging & Cognitive Support Supplements (CRADAGAM)

Headquarters

HQ city

Toronto

HQ country

Canada

HQ region

North America

Offices8 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Anti-Aging Products Sales: Sale of medical-grade stem cell anti-aging products including V-series products, stem cell rejuvenation therapies, and personalized longevity management services
2. Distribution Partnership Revenue: Revenue from distribution agreements with partners leveraging their retail networks; estimated $10-15 million annually from Chushanji partnership alone
3. Exclusive Distribution Agreements: $12 million exclusive distribution agreement with Huajin China for Premier Regenerative Complex with minimum contracted sales targets over 12-month period
4. Service Revenue: VIP health services and customized wellness programs including $9 million commercial sales agreement for Premier Regenerative Complex products and health services
5. Technology Licensing: Global licensing of stem cell technologies and regenerative medicine solutions to partners worldwide

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Core offering

Visionary Holdings sells medical-grade stem cell-based anti-aging products and regenerative medicine therapies to high-net-worth consumers and through enterprise distribution partners. The core portfolio includes the RAMU anti-aging line (targeting ~$30M annual sales), V-series anti-aging products, the Premier Regenerative Complex-President Super Injection injectable, NK Cell Revitalization therapies, AI-driven aging assessments, and personalized longevity management services. The company also distributes PEGASUS new energy vehicles and SBS Green Energy smart HVAC systems through Chinese regional subsidiaries and global partners.

Product overview

Visionary Holdings operates as a diversified conglomerate that has undergone strategic transformation from an education-technology company (IPO on Nasdaq in May 2022) into a biotechnology and healthcare enterprise focused on regenerative medicine and anti-aging solutions. The product portfolio centers on high-margin medical aesthetics and anti-aging offerings including the RAMU anti-aging product line (targeting $30M annual sales), Premier Regenerative Complex injectables, V-series anti-aging products distributed through China partnerships, and stem cell-based therapies through the Visionary Yike Stemcell Technologies joint venture. Complementary business segments include new energy vehicles (PEGASUS brand), green energy solutions (SBS/Smarco), education services, financial services, and real estate operations. The company operates through subsidiaries across North America and Asia, with regional commercialization matrices in the Shandong Peninsula, Yangtze River Delta, and Anhui markets in China.

Differentiator

Problem solved

Functional benefit

Brands

• Premier Regenerative Complex: Flagship anti-aging product including President Super Injection
• RAMU
• Visionary Yike Stemcell Technologies
• PEGASUS
• SBS Green Energy

Products and services

• Stem Cell-Based Anti-Aging Product Line Medical-grade stem cell anti-aging product line including stem cell rejuvenation therapies, NK cell revitalization, precision cellular repair programs, and AI-based diagnostic tools for high-net-worth individuals seeking full cellular rejuvenation, anti-aging interventions, and personalized longevity management services.
• Premier Regenerative Complex - President Super Injection Flagship anti-aging injectable product covered by a US$12 million exclusive distribution agreement with Huajin China Investment Company, establishing minimum contracted sales targets for Hong Kong market.
• V-Series Anti-Aging Products Anti-aging product portfolio distributed in China through Zhejiang Chushanji Digital Technology partnership, leveraging nearly 10,000 stores across five provinces with estimated annual revenue potential of $10-15 million.
• RAMU Anti-Aging Product Line Premium anti-aging product line targeted for approximately US$30 million in annual sales as part of the company's strategic shift toward healthcare services and medical aesthetics. Includes stem cell rejuvenation therapies and personalized longevity management services.
• BioTech Products (E7 Protein Kit, ChangleShuang Probiotics, Biochip) Biotechnology segment including E7 protein home self-testing kit for cancer screening, ChangleShuang Probiotics healthcare products, and biochip technologies. Positions company in precision health and diagnostics.
• SBS Green Energy (Smarco) Smart HVAC and Building Solutions HVAC and green energy solutions company offering fire protection systems, building automation control, cold storage installation, and AI-powered Building Energy Management Systems (BEMS) for smart energy optimization.
• PEGASUS New Energy Vehicles Electric vehicle brand offering compact smart electric sedans (400-500km range), mid-size luxury electric SUVs (500-600km range), and future models including pickup trucks and camper vans. Features intelligent interactive cockpits and ADAS systems.
• Conbridge College Education Programs Private career college offering programs in quality control, computerized accounting, global business management, computer network technology, business administration, and game design under Ontario's Private Career Colleges Act.
• Visionary Education Services (Legacy) Diverse education operations including Visionary High School, Toronto ESchool, HIS Traditional and Innovative School, MTM College, EdenCollege, Virtual Production programs, and Visa/Immigration services.

Quantifiable outcome

• $30 million projected annual sales for RAMU anti-aging product line 2026-2027
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core, minor and supporting.

• Qingdao Xihai Rongke Enterprise Operation Management Co., Ltd.coreStrategic or Co-development Partner · 31 March 2026$20 million investment cooperation agreement for anti-aging project in Qingdao West Coast New Area, China. Project includes GV China Anti-Aging Research Center and chain of GV Anti-Aging Health Management Centers. Investment in two phases focused on cell therapy, biologics research, and Sino-U.S. life sciences incubator. Milestone-based funding with additional $10 million potential. Target profitability within one year.
• Zhejiang Chushanji Digital Technology Co., Ltd.coreChannel Partner/ Reseller/ Distributor · 26 March 2026Strategic cooperation agreement to expand distribution of V-series anti-aging products in China. Partnership leverages Chushanji's extensive offline network of nearly 10,000 stores across 105 districts. Estimated potential annual revenues of $10-15 million if successful.
• Huajin China Investment CompanycoreChannel Partner/ Reseller/ Distributor · 2 March 2026US$12 million exclusive distribution agreement for Premier Regenerative Complex-President Super Injection anti-aging product. Minimum contracted sales target within 12-month period. Part of strategic shift toward high-margin medical aesthetics.
• Cai Dao Trading Ltd.minorOthers · 27 February 2026Acquisition of Visionary Education Services & Management Inc. non-core education business divestiture completed on February 27, 2026, marking strategic exit from legacy education operations.
• Jiangsu Yike Regenerative Medicine Co., Ltd.coreStrategic or Co-development Partner · 21 October 2025Strategic cooperation agreement to establish Visionary Yike Stemcell Technologies Inc., a Canada-based joint venture for advancing stem cell research, clinical application, and commercialization worldwide. GV holds 85% and Yike holds 15%. The joint venture focuses on stem cell therapy, immune cell engineering, and AI-supported anti-aging diagnostics, targeting diabetes treatment with breakthrough stem cell technology.
• Sikang (Guangzhou) Health Industry Investment Co., Ltd.supportingStrategic or Co-development Partner · 17 October 2025Completed controlling stake acquisition (51%) in joint venture focused on Traditional Chinese Medicine (TCM) health preservation. Leverages global capital and industrial resources to expand TCM health services internationally and domestically.
• Anhui Weikang Kangling Medical Technology Co., Ltd.supportingStrategic or Co-development Partner · 1 September 2025Cooperation consensus to jointly invest in building an Anti-Aging High-End Medical Aesthetics and Health Center within GV's Toronto property. Planned for anti-aging medical aesthetics services and health management.

Scale indicators12 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Mesoblast Limited: Clinical-stage biotechnology company developing allogeneic cellular medicines including stem cell therapies for inflammatory and degenerative diseases. Comparable as a stem cell therapeutics developer with global commercialization ambitions, paralleling Visionary Yike JV's diabetes stem cell pipeline.
• Jeunesse Global: Direct-selling company specializing in anti-aging skincare and wellness products targeting affluent consumers globally. Comparable in premium anti-aging consumer products with Asia-Pacific distribution focus, paralleling Visionary's V-series and Premier Regenerative Complex distribution strategy.
• Pluristem Therapeutics: Regenerative medicine company developing placenta-derived cell therapies for multiple indications. Comparable as a regenerative medicine peer pursuing commercial-stage cell therapy commercialization, overlapping with Visionary's cellular rejuvenation and stem cell positioning.
• Lineage Cell Therapeutics: Clinical-stage biotechnology company developing allogeneic cell therapies for neurodegenerative, oncology, and age-related conditions. Comparable as a regenerative medicine peer focused on cell-based therapeutics targeting age-related decline, similar to Visionary's anti-aging stem cell positioning.
• LifeVantage Corporation: Direct-to-consumer anti-aging and longevity supplement company selling products targeting cellular health, NRF2 activation, and NAD+ pathways. Comparable to Visionary's anti-aging consumer strategy and distribution model targeting health-conscious affluent consumers.

Broad incumbents

• Nu Skin Enterprises: Established global personal care and nutritional supplements company with significant anti-aging product lines and Asia-Pacific distribution strength. Comparable in targeting premium anti-aging consumer segments, particularly in Greater China markets where Visionary is building its platform.
• Herbalife Nutrition: Large global nutrition company with extensive distribution network for dietary supplements and wellness products. Comparable in nutritional supplements space and global multi-level distribution approach, particularly in Asia-Pacific markets relevant to Visionary's expansion.

Emerging players

• Geron Corporation: Late-stage clinical biopharmaceutical company developing telomerase inhibitor and cell therapy approaches for hematologic malignancies. Comparable as a peer in cell-based therapeutics with focus on telomerase-related mechanisms, similar to Visionary's telomerase homeostasis technology platform.
• AgeX Therapeutics: Biotechnology company focused on developing therapeutics targeting biological aging and age-related diseases using regenerative medicine approaches. Direct comparable in longevity biotechnology space, focused on cellular rejuvenation and age-related cellular decline.
• Elysium Health: Science-driven consumer health company developing NAD+ boosting and cellular health supplements targeting healthy aging. Comparable as a science-led longevity consumer brand, paralleling Visionary's positioning at the intersection of biotech credibility and consumer anti-aging products.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/FarvisionGroup
• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/visionary-education-technology-holdings-group-inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries10 records

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Visionary Holdings